- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00864188
The Influence of Probiotics in a Drinkable Yogurt on Skin Health
Phase 1 The Influence of Probiotics in a Drinkable Yogurt on Skin Health
Study Overview
Status
Conditions
Intervention / Treatment
- Dietary supplement: no bacterial strains
- Dietary supplement: One probiotic strain - Lactobacillus paracasei NCC2461
- Dietary supplement: Two standard yogurt fermenting bacterial strains - Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus
- Dietary supplement: Vit B2, B3, C and E, Beta Carotene and Oil
Detailed Description
This is a placebo-controlled, double blind, randomized, single center, human clinical trial aimed at assessing the influence of probiotics on skin health in healthy female subjects, when administered in a food matrix over a period of 5 months.
It will consist of five groups(40 subjects/group). The first group (1) of subjects will receive acidified milk that does not contain bacterial strains. The second group (2) will receive acidified milk that contains one specific probiotic strain. The third group (3) will receive fermented milk that contains a standard mix of yogurt bacterial strains. The fourth group (4) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 plus the same specific probiotic strain as in group 2. Finally, the fifth group (5) will receive fermented milk, containing the same standard mix of yogurt bacterial strains as in group 3 and 4 plus the same specific probiotic strain as in group 2 and 4 plus a mix of antioxidants.
This study will address whether:
A.The bioefficacy of a specific probiotic strain is influenced by a milk matrix.
B.Whether other bacterial strains impact the bioefficacy of this specific probiotic strain, and validate whether or not the bioefficacy is related entirely to the activity of this specific probiotic strain.
C.Whether nutritional supplements impact the bioefficacy of a specific probiotic strain.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Düsseldorf, Germany, 40225
- Institut für umweltmedizinische Forschung (IUF) an der Heinrich-Heine-Universität Düsseldorf gGmbH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy women as assessed by medical history and standard medical examination
- Caucasian
- Age: 25-55 y (inclusive)
- Normal BMI ≤ 30
- Skin type 1-111
- Regular Hormonal Cycle
- Having given his/her written informed consent
- Willing to avoid the consumption of fermented dairy products
- Minimum consumption of dark chocolate during the period of the study
Exclusion Criteria:
- Smoker
- Pregnant or lactating women
- Post menopausal women
- Heavy alcohol intake (usually consuming more than 3 standard drinks/day)
- Intake of chronic medications except oral contraceptive
- Vitamin and/or mineral and/or antioxidant supplementation over the 3 months preceding the initiation of the study and throughout the study.
- Having skin cancer or genetic disposition to skin cancer
- Regular exposure to artificial UVR
- Daily exposure to sun more than one week over the 2 months preceding the initiation of the study
- Planned vacation to sun during the period of the study.
- Excessive tea drinkers (more than 2 cups a day of green or black tea).
- Excessive consumer of fermented dairy products (more than 150g per day).
- Excessive consumer of dark chocolate (> 25g per day).
- Regular high exercise such as a marathon
- Subject who regularly takes saunas (dry or wet) or swims daily.
- Subject who cannot be expected to comply with treatment
- Currently participating or having participated in another interventional clinical trial during the last 3 months prior to the beginning of this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 1
Glucono-Delta-Lactone acidified milk containing no bacterial strains
|
Glucono-Delta-Lactone acidified milk containing no bacterial strains
|
|
Experimental: 2
Glucono-Delta-Lactone acidified milk containing one probiotic strain called Lactobacillus paracasei NCC2461.
|
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
|
|
Placebo Comparator: 3
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii subsp.bulgaricus.
|
Fermented milk containing two standard yogurt bacterial strains.
|
|
Experimental: 4
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii and one probiotic strain called Lactobacillus paracasei NCC2461.
|
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
Fermented milk containing two standard yogurt bacterial strains.
|
|
Experimental: 5
Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii, one probiotic strain called Lactobacillus paracasei NCC2461 and Vitamin B2,B3, C and E, Beta Carotene and an Oil.
|
Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.
Fermented milk containing two standard yogurt bacterial strains.
Fermented milk containing nutritional supplements
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Transepidermal water loss
Time Frame: baseline, 1 month, 2 months, 3 months, 5 months and 6 months
|
baseline, 1 month, 2 months, 3 months, 5 months and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Biopsy markers: transglutaminase, filagrin, involucrin, loricrin (mRNA)
Time Frame: baseline and at 5 months
|
baseline and at 5 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08.29.NRC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Health
-
Nag Food Supplement Trading LLCCitruslabsCompletedSkin Health | Hair Health | Joint HealthUnited States
-
SF Research Institute, Inc.RecruitingSkin Health | Hair HealthUnited States
-
ESM Technologies, LLCCompletedSkin Elasticity | Skin Hydration | Hair Health | Skin Barrier to Water Loss | Fingernail HealthUnited States
-
Hungkuang UniversitySchweitzer Biotech CompanyActive, not recruitingSkin Condition | Skin Health | Eyelashes | Hair Health | Eyelash GrowthTaiwan
-
Manuka HealthCitruslabsCompleted
-
SahajanCitruslabsCompletedSkin HealthUnited States
-
Thu BruléCitruslabsCompleted
-
PharmanexDermatology Consulting Services, High Point NCCompletedSkin HealthUnited States
-
Mundipharma Manufacturing Pte Ltd.Genome Institute of SingaporeCompleted
-
Habelo BeautyCitruslabsCompletedSkin Care | Skin Health | DermatologyUnited States
Clinical Trials on no bacterial strains
-
Université Catholique de LouvainRecruitingUrinary Tract Infections | Patients With Suprabubic Catheter | Patients With Nephrostomy CatheterBelgium
-
University of ChicagoRecruitingLiver Diseases | Liver Failure | Cirrhosis, LiverUnited States
-
AB Biotics, SACompletedModerate HypercholesterolemiaFrance
-
Nutri & CoNot yet recruitingMicrobial Colonization
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
Cancer Institute and Hospital, Chinese Academy...Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control; National Institute for the Control of Pharmaceutical and Biological Products, ChinaCompleted
-
Universitair Ziekenhuis BrusselBioGaia ABRecruitingColic | Healthy Infants | Eczema Atopic DermatitisBelgium
-
Bionou Research, S.L.Biopolis S.L.TerminatedAtopic DermatitisSpain, Bolivia, Costa Rica
-
University of VermontNaval Medical Research Center; TD Vaccines A/SUnknownCampylobacter InfectionsUnited States
-
Winclove B.V.AlyatecRecruitingPerennial Allergic RhinitisFrance